Despite the disease’s name, 2020 was the year of Covid-19. And the fate of small and medium-sized medtech players last year largely hinged on their ability to avoid the worst of the fallout from the pandemic – or, sometimes, to embrace it.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,